
Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW: Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.
moreShow CYTHW Financials
Recent trades of CYTHW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CYTHW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CYTHW's company Twitter account
Number of mentions of CYTHW in WallStreetBets Daily Discussion
Recent insights relating to CYTHW
Recent picks made for CYTHW stock on CNBC
ETFs with the largest estimated holdings in CYTHW
Flights by private jets registered to CYTHW